Resveratrol Exerts Anti-Aging Effects in Young but Pro-Aging Effects in Middle-Aged C. elegans via a Gerosuppressive daf-16/dod-6/sod-3 Axis.

Mei-Ling Ou, Jin-Xiong Cen, Cao-Yan Qi, Yong-Zhuo Li, Zhen-Zhen Yu, Jia-Jun Tu, Kun Xue, Jing Zhou, Guo-Dong Lu

Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, P.R. China, 530021; Fangchenggang Center for Disease Control and Prevention, Fangchenggang, Guangxi Province, China, 538021.Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, P.R. China, 530021; Fangchenggang Center for Disease Control and Prevention, Fangchenggang, Guangxi Province, China, 538021. · pubmed

Paper

Abstract

Aging, a complex process influenced by genetic and environmental factors, is a major determinant of health and disease. The polyphenolic compound resveratrol, known for its antioxidant properties, has been widely studied for its potential anti-aging effects. In this study, we investigated the age-dependent effects of resveratrol in Caenorhabditis elegans (C. elegans). Treatment with resveratrol for four consecutive days in young worms (adulthood day 1-4) significantly enhanced lifespan, healthspan, and reduced reactive oxygen species (ROS) generation. In contrast, the same treatment in middle-aged worms (adulthood day 8-11) unexpectedly impaired these phenotypes. Genetic experiments using mutant strains and RNA interference revealed that the gerosuppressor daf-16 and its downstream antioxidant sod-3 mediate these age-specific effects, as deletion of daf-16 or silencing of sod-3 eliminated the age-dependent opposing responses. Transcriptomic analysis identified distinct gene expression patterns between young and middle-aged worms, with the daf-16-regulated gene dod-6 being up-regulated in young worms but down-regulated in middle-aged worms. Silencing dod-6 abolished the age-dependent opposing effects on lifespan, healthspan, and ROS generation. Further studies confirmed that daf-16 regulates sod-3 through dod-6. Then, the divergent effects of resveratrol were validated in human fibroblast BJ cells: resveratrol reduced β-galactosidase staining and pro-inflammatory cytokine expression in normal cells but exacerbated these markers in D-galactose-induced senescent cells. Together, these findings demonstrate that resveratrol exerts anti-aging effects in young organisms but promotes aging in middle-aged organisms, likely through differential regulation of the daf-16/dod-6/sod-3 axis. This study highlights the importance of understanding age-related drug susceptibility to develop safer and more effective anti-aging interventions.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Resveratrol extends healthspan and lifespan in young C. elegans via the daf-16/dod-6/sod-3 axis but impairs these metrics in middle-aged worms, a finding validated in human fibroblasts. This study is relevant as it directly addresses age-dependent responses to a popular longevity intervention, but the impact is minor because it confirms known complexities of resveratrol bioavailability and signaling without offering a novel, transformative mechanism for lifespan extension.

Author of this paper? Send a correction.